Form 4 Tracker
Keros Therapeutics, Inc.
KROS

13 insider filings · Latest: Apr 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 15, 2026Apr 17 8:15 PMJean Jacques BienaimeDirector
Purchase
1,000$11.70$11.7K8,450(D)

View →

Mar 31, 2026Apr 1 1:57 AMOrbiMed Genesis Master Fund, LP
Proposed Sale
45,057$11.04$497.4K

View →

Mar 9, 2026Mar 11 8:33 PMJean Jacques BienaimeDirector
Purchase
2,000$11.21$22.4K7,450(D)

View →

Feb 19, 2026Feb 20 9:15 PMJasbir SeehraDirector, CHIEF EXECUTIVE OFFICER
Sale
7,015$16.17$113.4K385,708(D)

View →

Feb 18, 2026Feb 20 9:15 PMLorena Raquel LernerChief Science Officer
Sale
3,873$16.35$63.3K31,127(D)

View →

Feb 18, 2026Feb 20 9:15 PMEsther ChoSVP, General Counsel
Sale
4,745$16.35$77.6K39,755(D)

View →

Feb 18, 2026Feb 20 9:15 PMKeith RegnanteCHIEF FINANCIAL OFFICER
Sale
4,739$16.35$77.5K39,261(D)

View →

Sep 12, 2025Sep 12 8:45 PMRovaldi Christopher
Proposed Sale
85,306$15.71$1.3M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 2, 2026Apr 6 8:15 PMJasbir SeehraDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
55,000$0.30197,444(D)

View →

Feb 24, 2026Mar 27 8:15 PMEsther ChoChief Legal Officer
Grant/Award
80,000$15.5280,000(D)

View →

Mar 9, 2026Mar 11 8:39 PMCharles W. NewtonDirector
Grant/Award
14,788$11.3514,788(D)

View →

Feb 24, 2026Feb 26 9:15 PMJasbir SeehraDirector, CHIEF EXECUTIVE OFFICER
Grant/Award
317,000$15.52100,000(D)

View →

Feb 24, 2026Feb 26 9:15 PMKeith RegnanteCHIEF FINANCIAL OFFICER
Grant/Award
60,000$15.5260,000(D)

View →

Feb 24, 2026Feb 26 9:15 PMEsther ChoChief Legal Officer
Grant/Award
80,000$15.5280,000(D)

View →

Feb 24, 2026Feb 26 9:15 PMLorena Raquel LernerChief Scientific Officer
Grant/Award
75,000$15.5275,000(D)

View →